EDITAS MEDICINE INC.
2.3800
25-November-24 16:45:01
15 minutes delayed
Stocks
-0.0600
-2.46%
Today's range
2.3450 - 2.5300
ISIN
N/A
Source
NASDAQ
-
Editas Medicine Announces First Quarter 2021 Results and Update
05 May 2021 07:00:01 By Nasdaq GlobeNewswire
-
Editas Medicine Names Mark S. Shearman, Ph.D., as Chief Scientific Officer
05 May 2021 06:59:00 By Nasdaq GlobeNewswire
-
Editas Medicine to Host Conference Call Discussing First Quarter 2021 Results and Corporate Update
28 Apr 2021 07:01:00 By Nasdaq GlobeNewswire
-
Editas Medicine Announces Fourth Quarter and Full Year 2020 Results and Update
25 Feb 2021 07:00:03 By Nasdaq GlobeNewswire
-
18 Feb 2021 16:02:00 By Nasdaq GlobeNewswire
-
Editas Medicine Announces Appointment of James C. Mullen as Chief Executive Officer
08 Feb 2021 08:00:00 By Nasdaq GlobeNewswire
-
Editas Medicine Announces Pricing of Offering of Common Stock
20 Jan 2021 22:30:00 By Nasdaq GlobeNewswire
-
Editas Medicine Announces Offering of Common Stock
19 Jan 2021 16:01:00 By Nasdaq GlobeNewswire